Increased transmission of Mycobacterium tuberculosis Beijing genotype strains associated with resistance to streptomycin: A population-based study

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Buu, Tran N ^a   van Soolingen, Dick ^b,c   Huyen, Mai N T ^a   Lan, Nguyen T N ^a   Quy, Hoang T ^a   Tiemersma, Edine W ^d,e   Kremer, Kristin ^f   Borgdorff, Martien W ^g   Cobelens, Frank G J ^e,h  

^a Pham Ngoc Thach Hospital   (Viet Nam)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^e AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g MUNICIPAL HEALTH SERVICE   (Netherlands)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; STREPTOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA FINGERPRINTING; DRUG EFFECT; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RISK FACTOR; SPUTUM SMEAR; STRAIN DIFFERENCE;

ADULT; AGED; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; RURAL POPULATION; STREPTOMYCIN; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84865052945     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042323     Document Type: Article

References (47)

1. WHO (2010) Global tuberculosis control 2010: epidemiology, strategy, financing. Geneva: World Health Organization. vii, 204 p.
2. WHO (1994) Global Tuberculosis Programme: a global emergency, WHO report on the TB epidemic. Geneva: World Health Organization. 28 p. p.
3. WHO (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: World Health Organization. x, 58 p.
4. Mitchison DA, (1998) How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 2: 10-15.
5. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, et al. (1995) Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 33: 3234-3238.
6. Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, et al. (2004) Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol 42: 4040-4049.
7. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis (2006) Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 12: 736-743.
8. Devaux I, Kremer K, Heersma H, Van Soolingen D, (2009) Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe. Emerg Infect Dis 15: 1052-1060.
9. Dou HY, Tseng FC, Lin CW, Chang JR, Sun JR, et al. (2008) Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis in Taipei. BMC Infect Dis 8: 170.
10. Cowley D, Govender D, February B, Wolfe M, Steyn L, et al. (2008) Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis 47: 1252-1259.
11. Jou R, Chiang CY, Huang WL, (2005) Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. J Clin Microbiol 43: 95-100.
12. Glynn JR, Crampin AC, Traore H, Yates MD, Mwaungulu FD, et al. (2005) Mycobacterium tuberculosis Beijing genotype, northern Malawi. Emerg Infect Dis 11: 150-153.
13. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Garcia I, et al. (2001) Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med 164: 1165-1170.
14. de Jong BC, Hill PC, Aiken A, Awine T, Antonio M, et al. (2008) Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 198: 1037-1043.
15. Sun YJ, Luo JT, Wong SY, Lee AS, (2010) Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from Singapore. Clin Microbiol Infect 16: 287-289.
16. Hillemann D, Kubica T, Agzamova R, Venera B, Rusch-Gerdes S, et al. (2005) Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Int J Tuberc Lung Dis 9: 1161-1167.
17. Ebrahimi-Rad M, Bifani P, Martin C, Kremer K, Samper S, et al. (2003) Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 9: 838-845.
18. Baranov AA, Mariandyshev AO, Mannsaker T, Dahle UR, Bjune GA, (2009) Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia. Int J Tuberc Lung Dis 13: 1288-1293.
19. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, et al. (2000) Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 6: 302-305.
20. Buu TN, Huyen MN, Lan NT, Quy HT, Hen NV, et al. (2009) The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam. Int J Tuberc Lung Dis 13: 900-906.
21. Lan NT, Lien HT, Tung le B, Borgdorff MW, Kremer K, et al. (2003) Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 9: 1633-1635.
22. Buu TN, Huyen MN, van Soolingen D, Lan NT, Quy HT, et al. (2010) The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam. Clin Infect Dis 51: 879-886.
23. Huong NT, Lan NT, Cobelens FG, Duong BD, Co NV, et al. (2006) Antituberculosis drug resistance in the south of Vietnam: prevalence and trends. J Infect Dis 194: 1226-1232.
24. WHO (2003) Global Tuberculosis Programme: Treatment of tuberculosis: guidelines for national programmes. Geneva: World Health Organization. 108 p.
25. WHO (2009) Guidelines for surveillance of drug resistance in tuberculosis. Geneva: World Health Organization. xii, 83 p.
26. van Soolingen D, de Haas PE, Kremer K (2001) Restriction fragment length polymorphism typing of mycobacteria. In: Mycobacterium tuberculosis protocols, eds. T. Parish and N.G. Stoker. Humana Press Inc., Totowa NJ. Chapter 12, page 165-203.
27. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, et al. (1993) Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31: 406-409.
28. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35: 907-914.
29. Institute de Biologie- Institute Pasteur the Lille Multilocus variable number tandem repeat genotyping of Mycobacterium tuberculosis. Technical guide, 2005.
30. Heersma HF, Kremer K, van Embden JDA (1998) Computer analysis of IS6110 RFLP patterns of Mycobacterium tuberculosis. In: TParish and N.G. Stoker (ed), Methods in Molecular Biology, vol. 101: Mycobacteria protocols. Humana press Inc., Totowa, NJ.
31. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, et al. (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6: 23.
32. Braden CR, Templeton GL, Cave MD, Valway S, Onorato IM, et al. (1997) Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 175: 1446-1452.
33. Braden CR, Morlock GP, Woodley CL, Johnson KR, Colombel AC, et al. (2001) Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis 33: e42-47.
34. Samper S, Iglesias MJ, Rabanaque MJ, Gomez LI, Lafoz MC, et al. (2005) Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain. J Clin Microbiol 43: 1220-1227.
35. Kubica T, Rusch-Gerdes S, Niemann S, (2004) The Beijing genotype is emerging among multidrug-resistant Mycobacterium tuberculosis strains from Germany. Int J Tuberc Lung Dis 8: 1107-1113.
36. Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, et al. (2002) Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 40: 1930-1937.
37. Verver S, Warren RM, Munch Z, Vynnycky E, van Helden PD, et al. (2004) Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epidemiol 33: 351-357.
38. Glynn JR, Bauer J, de Boer AS, Borgdorff MW, Fine PE, et al. (1999) Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis 3: 1055-1060.
39. van Soolingen D, de Haas PE, van Doorn HR, Kuijper E, Rinder H, et al. (2000) Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis 182: 1788-1790.
40. Gagneux S, Burgos MV, DeRiemer K, Encisco A, Munoz S, et al. (2006) Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog 2: e61.
41. Huyen MN, Tiemersma EW, Lan NT, Cobelens FG, Dung NH, et al. (2010) Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect Dis 10: 149.
42. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, et al. (1996) Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275: 452-457.
43. Githui WA, Jordaan AM, Juma ES, Kinyanjui P, Karimi FG, et al. (2004) Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya. Int J Tuberc Lung Dis 8: 352-360.
44. Quy HT, Cobelens FG, Lan NT, Buu TN, Lambregts CS, et al. (2006) Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 10: 45-51.
45. Houben RM, Crampin AC, Mallard K, Mwaungulu JN, Yates MD, et al. (2009) HIV and the risk of tuberculosis due to recent transmission over 12 years in Karonga District, Malawi. Trans R Soc Trop Med Hyg 103: 1187-1189.
46. DeRiemer K, Kawamura LM, Hopewell PC, Daley CL, (2007) Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics. Am J Respir Crit Care Med 176: 936-944.
47. Ministry of Health HIV/AIDS estimates and projections 2005-2010. Hanoi, Viet Nam, 2005.